Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Safety and Efficacy of Allogeneic NK Cell Therapy for Recurrent/Refractory Elderly AML
Authors not listed
The Second Hospital of Shandong University · 2020
Abstract
The aim of this investigation was to assess safety and efficacy of allogenic NK cells therapy for recurrent refractory elderly AML.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
Anonymous. (2020). Safety and Efficacy of Allogeneic NK Cell Therapy for Recurrent/Refractory Elderly AML. <em>The Second Hospital of Shandong University</em>. https://clinicaltrials.gov/study/NCT04599452
Vancouver
Anonymous. Safety and Efficacy of Allogeneic NK Cell Therapy for Recurrent/Refractory Elderly AML. The Second Hospital of Shandong University. 2020.
BibTeX
@misc{anon2020Safety,
title = {Safety and Efficacy of Allogeneic NK Cell Therapy for Recurrent/Refractory Elderly AML},
author = {Anonymous},
journal = {The Second Hospital of Shandong University},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Vinmec Research Institute of Stem Cell and Gene Technology 2021
Open access · US-GOV
Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation
Huiqiang Huang 2021
Open access · US-GOV
Tislelizumab in Combination With Lenalidomide in in Patients With Relapsed or Refractory Elderly Patients With Non-GCB Diffuse Large B Cell Lymphoma: a Prospective Phase Ib/II, Multicentre, Open-label, Single-arm Trial
Beijing Immunochina Medical Science & Technology Co., Ltd. 2020
Open access · US-GOV
Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma
Chinese Academy of Sciences 2018
Open access · US-GOV
Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
Hellenic Oncology Research Group 2010
Open access · US-GOV
First Line Treatment of Elderly Patients With Advanced or Metastatic NSCLC With Docetaxel and Bevacizumab
CHEST Journal 2020
Citation only